Date Filed | Type | Description |
02/14/2014 |
SC 13G/A
| APAX PARTNERS EUROPE MANAGERS LTD reports a 0% stake in Astex Pharmaceuticals, Inc. |
10/11/2013 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
10/11/2013 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
10/11/2013 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
10/11/2013 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
10/11/2013 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
10/11/2013 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
10/11/2013 |
8-K
| Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Sta... |
10/11/2013 |
SC 14D9/A
| Form SC 14D9/A - Solicitation, recommendation statements: [Amend] |
10/11/2013 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party: [Amend] |
10/10/2013 |
SC 14D9/A
| Form SC 14D9/A - Solicitation, recommendation statements: [Amend] |
10/09/2013 |
SC 14D9/A
| Form SC 14D9/A - Solicitation, recommendation statements: [Amend] |
10/08/2013 |
SC 14D9/A
| Form SC 14D9/A - Solicitation, recommendation statements: [Amend] |
10/08/2013 |
SC 14D9
| Form SC 14D9 - Solicitation, recommendation statements: |
10/07/2013 |
SC 14D9/A
| Form SC 14D9/A - Solicitation, recommendation statements: [Amend] |
10/07/2013 |
SC TO-T/A
| Form SC TO-T - Tender offer statement by Third Party [amend] |
09/05/2013 |
SC 14D9
| Form SC 14D9 - Solicitation, recommendation statements |
09/05/2013 |
SC 14D9
| Form SC 14D9 - Solicitation, recommendation statements |
09/05/2013 |
8-K
| Quarterly results |
08/09/2013 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans |
08/09/2013 |
10-Q
| Quarterly Report for the period ended June 30, 2013 |
08/01/2013 |
8-K
| Quarterly results |
05/10/2013 |
10-Q
| Quarterly Report for the period ended March 31, 2013 |
04/29/2013 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
04/29/2013 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements |
04/29/2013 |
8-K
| Quarterly results |
03/18/2013 |
10-K
| Annual Report for the period ended December 31, 2012 |
01/18/2013 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans |
11/09/2012 |
10-Q
| Quarterly Report for the period ended September 30, 2012 |
10/30/2012 |
8-K
| Quarterly results |
09/28/2012 |
8-K
| Other Events, Financial Statements and Exhibits |
08/09/2012 |
10-Q
| Quarterly Report for the period ended June 30, 2012 |
07/30/2012 |
8-K
| Form 8-K - Current report |
06/28/2012 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs:
|
"Contract of Employment effective June 22, 2012 by and between Astex Therapeutics Limited and Dr. Harren Jhoti",
"Confidentiality and Proprietary Information Deed effective June 22, 2012 by and between Astex Pharmaceuticals, Inc., Astex Therapeutics Limited, and Dr. Harren Jhoti",
"Contract of Employment effective June 22, 2012 by and between Astex Therapeutics Limited and Martin Buckland",
"Confidentiality and Proprietary Information Deed effective June 22, 2012 by and between Astex Pharmaceuticals, Inc., Astex Therapeutics Limited, and Martin Buckland",
"Severance Benefit Plan for Officers effective June 22, 2012" |
|
|